A B S T R A C T WVe studied the effect of cholecystokinin (CCK) and the octapeptide of cholecystokinin (OP-CCK) on the feline gallbladder and sphincter of Oddi. Both CCK caused a dose-dependent gallbladder contraction and sphincter of Oddi relaxation. The halfmaximal responses of the sphincter of Oddi were 6 ng/kg for OP-CCK and 0.15 Ivy-dog U/kg for CCK, which were lower than those ofthe gallbladder wvith 28 ng/kg and 0.32 Ivy-dog U/kg, respectively. The effect of OP-CCK on the gallbladder was partially blocked by tetrodotoxin (P < 0.02), hexamethonium alone (P < 0.05), or a combination of hexamethonium and atropine (P < 0.01). The gallbladder response to CCK wvas not blocked by either atropine alone (P < 0.60) or adrenergic anitagonists (P > 0.40). The sphincter of Oddi response to OP-CCK was blocked by tetrodotoxin (P < 0.001) but it was not blocked by cholinergic (P < 0.20) or adrenergic antagonists (P < 0.60). After comiplete denervation with tetrodotoxin, OP-CCK caused sphincter of Oddi contraction. These findings indicate that there are two excitatory receptors for CCK in the gallbladder, one at the cholinergic neurons and the other at the level of the gallbladder muscle. There are also tvvo receptors for CCK in the sphincter of Oddi, one that is inhibitory, and present at the noncholinergic, nonadrenergic neurons, and the other, excitatory, at the circular muscle.
INTRODUCTION
Cholecvstokinin (CCK)1 causes contraction of the gallbladder in man and experimental animals (1) (2) (3) . In vitro studies have shown that this CCK effect results from direct hormonal action on gallbladder musele (4, 5) . It has been proposed that this action of CCK on the gallbladder is physiological (6) . The effect of CCK on the sphincter of Oddi (SO), however, is controversial. While most studies have shown that CCK relaxes the SO (7) (8) (9) , one has demonstrated SO contraction (10) . Moreover, the mechanism of action of CCK on the SO has not been conclusively elucidated (11, 12) .
The present studies were designed to determine, in vivo, the mechanism of action of CCK on the gallbladder, the CCK effect on the SO, and its mechanism of action on the SO. NIETHODS 72 adult cats of either sex weighing 2-5 kg wvere studied. The animals were anesthetized with intramuscutlar Ketainiiie hydrochloride (30 mg/kg body wt) and maintained with small doses of [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] mg/kg as needed. Thev were studied in the supine position with a constant slow intravenouis infusion of Ringer's solution with 5% dextrose. Respiration was assisted and controlled with a ventilator (Harvard Apparatus Company, Inc., model N-607, S. Natick, Mass.) through a tracheostomy tube. Arterial blood pressure was Abbreviations used in this paper: CCK, cholecystokinin; D50, dose that cauises half-maximal response; LES, lower esophageal sphincter; OP-CCK, octapeptide of cholecystokinin; SO, sphincter of Oddi; TTX, tetradotoxin.
continuously monitored through a cannula placed in the femoral artery.
After a midline abdominal incision the gallbladder and biliary tree were identified. The cystic duct was isolated and cannulated with a catheter with an o.d. of 1.57 mm, preserving its neural and blood supply. The integrity ofthe innervation of the gallbladder was tested by stimulating both ends of the cervical vagus and the splanchnic nerves. The gallbladder responded with contraction to each stimulation (13) . After the gallbladder had been emptied, 3 ml of normal saline was introduced. The cannula, filled with saline, was tied in the cystic duct using the purse-string technique to keep it in position and to avoid any leaks. Pressures were measured with a Statham pressure transducer (Gould-Statham Instruments, Inc., Hato Rey, Puerto Rico). The volume of 3 ml was used because: (a) preliminary studies had shown that the mean fasting gallbladder volume in 12 animals was 3 ml of bile, and (b) maximal gallbladder response to a maximal dose of OP-CCK (100 ng/kg) was observed with this gallbladder volume. A pressure increment of 1.5±0.3 mm Hg was observed when the gallbladder volume was 1 ml; when 2 ml of saline were introduced, the increment was 1.9±0.5 mm Hg; with 3 ml of saline, its response was 2.4+0.6 mm Hg; finally, with 4 ml of saline, its response was 2.2±0.8 mm Hg. Gallbladder pressure was usually stable, but if any decline in pressure was observed, the gallbladder was emptied, and the same volume of normal saline was again introduced. This manometric method was capable of detecting accurately and reproducibly gallbladder contraction with bethanechol and relaxation with isoproterenol.
The SO pressures were measured using a modification of a previously reported method (14) . A constantly perfused (0.3 ml/min), open-tipped, large catheter (o.d. = 1.57 mm) was used. This catheter was placed in the common bile duct, advanced until resistance was encountered, and then withdrawn 1 mm. At this point, it was anchored with a tight loop of suture silk, using the purse-string technique. The catheter was large enough to occupy almost the entire lumen ofthe common bile duct, and the tight loop prevented retrograde flow. Pressures thus recorded were reflections of the SO resistance to flow.
To validate this manometric method, the following preliminary studies were performed: (a) Simultaneous pressure measurements ofthe SO and second portion ofthe duodenum showed that the SO pressures were [15] [16] [17] [18] [19] [20] Calif.); isoproterenol, 4 ,ug/kg (Whinthrop Laboratories, New York); nicotine, 100 ,g/kg (Eastman Kodak Co., Rochester, N. Y.). Each pharnacological antagonist was used in a sufficient dose to block the dose of its agonist that produced a maximal effect on the SO and gallbladder.
Tonic gallbladder and SO pressures were measured as mean endexpiratory pressures over a 5-min period immediately before and 30 min after the administration of a pharmacological antagonist. SO phasic contractions were measured as mean amplitude ofthe contractions above tonic pressures over a 5-min period immediately before and 30 min after the administration ofthe pharmacological antagonist. The effect of short-acting pharmacological agonists and gastrointestinal hormones was determined as the peak or nadir of pressures observed within a 10-min period after their administration.
The paired and unpaired Student's t tests were used for statistical analysis.
RESULTS

Effect of CCK and OP-CCK on the gallbladder and SO
Basal gallbladder pressures were stable and only influenced by respiratory excursions (Fig. 1) . The Hg after addition of atropine (P < 0.60). Similar results were observed when dose-response studies with OP-CCK (1-200 ng/kg) were carried out before and after addition of atropine (P > 0.05, Fig. 4) . Hexamethonium, however, caused a slight gallbladder relaxation (Table   I) (Table I ). The combination of these two antagonists decreased gallbladder contraction resulting from CCK from 2.5+0.5 to 1.1+0.2 mm Hg (P < 0.01). Likewise, these two cholinergic antagonists reduced gallbladder contraction in response doses of OP-CCK from ng/kg (P < 0.01, Fig. 4) .
To investigate the ability of hexamethonium, and combined atropine and hexamethonium to partially block the action of OP-CCK on the gallbladder, studies were carried out with nicotine before and after atropine was added and with atropine and hexamethonium combined. A maximal dose of nicotine (100 ,ug/kg) increased gallbladder pressures in six experiments by 2.0+0.5 mm Hg. Administering atropine at doses that blocked a maximal dose of bethanechol (40 ,ug/kg) did not completely antagonize the nicotine effect on the gallbladder. It reduced the gallbladder pressure increment to 0.9±0.2 mm Hg (P < 0.01). The gallbladder, however, did not respond to nicotine at all after the administration of hexamethonium (P < 0.01). Effect of adrenergic blocking agents. Maximal doses of propranolol or phentolamine did not significantly affect tonic gallbladder pressures (Table I) (Fig. 6 ). The dose (12 ,ug/kg) that blocked vagally induced relaxation of the SO was not large enough to antagonize the CCK effect. Doses of up to 36 ,ug/kg of TTX were needed to block the OP-CCK-induced relaxation, and at that point OP-CCK (100 ng/kg) caused contraction ofthe SO (Fig. 7) . The SO, however, was still able to relax in response to stimuli, such as isoproterenol, that act directly on smooth muscle (Fig. 8) . To further examine the nature ofthe TTX antagonism to OP-CCK in the SO, we performed a dose-response study with OP-CCK from 1 to 200 ng/kg before and after TTX (36 ,ug/kg). Before TTX, the SO relaxed in response to all doses of OP-CCK (1-200 ng/kg), whereas after TTX, it responded with contraction to doses of 5 to 200 ng/kg (Fig. 9) .
Effect of isoproterenol on the gallbladder response to OP-CCK. Because the gallbladder response to OP-CCK was partially blocked by TTX and by combined hexamethonium and atropine, antagonists that also reduce basal gallbladder pressures, we examined the possibility that the reduced gallbladder response to OP-CCK was a result of lower basal pressures. We therefore performed an experiment in which basal gallbladder pressures were reduced by the same magnitude observed after the addition ofthese pharmacological antagonists. This was accomplished by using a constant isoproterenol infusion (2 ,ug/kg per min) that reduced pressures by 20-30%. The OP-CCK doseresponse curves before and during the infusion of isoproterenol were not significantly different (P > 0.05, Fig. 10 ).
DISCUSSION
The results ofthis study indicate that both CCK and OP-CCK cause simultaneous gallbladder contraction and SO relaxation. The minimal and maximal doses of both CCK that caused gallbladder contraction and SO relaxation were similar. However, the D50 of CCK and OP-CCK was lower for the SO than for the gallbladder. Since the effect of CCK on the gallbladder is considered to be one ofthe physiological actions ofthis gastrointestinal hormone (6), these findings suggest that the CCK-induced relaxation ofthe SO may also be physiological. Further studies, however, are needed to demonstrate this assumption and meet the criteria for proof of the physiological action of gastrointestinal hormones (15) . Pharmacological analysis of the mechanism of the CCK action indicates that there are two excitatory receptors in the gallbladder. CCK appears to cause contraction by direct action on the gallbladder muscle, because it was not inhibited completely by any neural antagonist used, including TTX. Cholinergic antagonists, such as hexamethonium alone or in combination with atropine, caused a partial block of the gallbladder response to CCK. Similar results were obtained when the gallbladder was denervated with TTX. These observations suggest a second receptor for CCK at the postganglionic cholinergic neurons. The failure of atropine alone to antagonize the CCK action, however, would indicate the existence of a nicotinic as well as muscarinic receptor for acetylcholine at the gallbladder muscle (16) . Alternatively, the failure of atropine alone could suggest the presence of a cholinergic pathway with synaptic transmission to an excitatory noncholinergic, nonadrenergic neuron. These hypotheses are supported by our studies with nicotine, which caused gallbladder contraction that was partially antagonized by atropine. Complete block of the nicotine action requires the specific nicotinic blocker, hexamethonium. These findings also agree with our previous studies on the nature Qf the excitatory vagal fibers innervating the feline gallbladder (13) . We found that gallbladder contraction, resulting from electrical stimulation of the peripheral or central ends of the cervical vagus, is not affected by atropine alone but is antagonized entirely by atropine and hexamethonium. Our present findings are also consistent with other studies that have demonstrated CCK receptors at the intramural cholinergic neurons in the guinea pig ileum and antrum (17, 18) . Those studies showed that CCK can stimulate the release of acetylcholine in the ileum (17) . In contrast, in vitro experiments have shown an exclusive CCK direct muscle action on the guinea pig gallbladder that was not impaired by atropine or even TTX (4). In the in vitro studies, however, no attempt was made to determine whether the intrinsic cholinergic innervation of the gallbladder was functionally intact. Neurons are more sensitive to hypoxia than smooth muscle cells, and it is thus possible that these in vitro studies have dealt with almost pure muscle preparations (19) . Alternatively, these dissimilarities could be the result of species differences.
The relaxation of the SO induced by CCK is not antagonized by adrenergic or cholinergic blocking agents. These findings agree with previous studies that failed to demonstrate any cholinergic or adrenergic antagonism to the CCK inhibition ofthe SO (11, 12, 20) .
We concluded that the CCK action was a direct hormonal effect on the SO circular muscle. Cholinergic and adrenergic antagonists do not entirely denervate the SO, however, and TTX treatment was necessary. These results would suggest that CCK stimulates intramural, noncholinergic, nonadrenergic inhibitory neurons. As for the feline lower esophageal sphincter (LES) (21) , the dose of TTX needed to block CCK action on the SO was 36 ,glkg, a dose greater than the one needed to block the SO response to vagal stimulation. (23) but not in the feline LES (21) . Furthermore, these intramural inhibitory neurons of the SO were more sensitive to this hormone than those of the LES. The D50 of OP-CCK required to inhibit SO pressures was 6 ng/kg, compared with 100 ng/kg needed to attain a half-maximal response of the LES (21) . The existence ofthese intramural non-cholinergic, non-adrenergic neurons in the SO is further supported by the finding that nicotine causes SO relaxation which is blocked by TTX. 2 Recent studies have shown that the net effect of a gastrointestinal hormone or a pharmacological agent is the result of the algebraic sum of the actions of the stimulated receptors at the neuromuscular structure under study (21, 24) . In the SO, the net CCK effect is a drop in pressure, indicating the predominance of inhibitory receptors. After complete SO denervation with TTX, a second CCK receptor is unmasked that mediates SO contraction, suggesting a direct action on its circular muscle. This second CCK action may be related to the presence of a terminal tetrapeptide molecule shared with gastrin.
In conclusion, these studies indicate the existence of four types of receptors for CCK in the biliary tree. The gallbladder has two excitatory receptors, one at the muscle, and the other, most likely, at the intramural postganglionic cholinergic neuirons. The SO also has two receptors: one inhibitory, most likely present at the intramural, inhibitory, noncholinergic, nonadrenergic, postganglionic neurons; the other excitatory, present at the circular muscle of the SO. The presence after denervation with TTX of four different receptors for CCK in the biliary tree creates an interesting experimental model. This experimental model may explain certain forms of postprandial right-upperqiuadrant pain attributed to one of the poorly defined syndromes of biliary dyskinesia (25, 26) . Under these pathophysiological conditions, with absence of intramural ganglion cells, release of CCK by its physiological stimuli could cause simultaneous contractions in both gallbladder and SO, resulting in marked increase in intraductal pressures, and possibly in pain.
Obviously, further studies are necessary to establish whether the functional post-prandial upper abdominal pain of some patients can be explained on the basis of this proposed hypothesis.
